The Demodex Clinical Education Hub
This website is independently editorial supported by advertising from Tarsus Pharmaceuticals.
The Hidden Drivers: 12-Episode Video Series
Is Demodex the Missing Link in MGD?
Join Drs. Mile Brujic and Laura M. Periman as they provide insights into the link between Demodex blepharitis and meibomian gland dysfunction (MGD).
The Ocular Surface Burden in Glaucoma: What the Evidence Actually Shows
Join Drs. Brujic and Schmidt as they discuss pearls for managing patients with concomitant ocular surface disease, Demodex blepharitis, and glaucoma.
Additional Content
How Demodex Blepharitis Affects Meibomian Gland Structure and Function
Join Drs. Gupta and Koetting as they discuss findings from a new study on the relationship between Demodex blepharitis and meibomian gland dysfunction.
Diagnosing Demodex Blepharitis: The Patient Conversation
Join Preeya K. Gupta, MD and Julio Cesar Albarracin, MD, to review when to use XDEMVY for Demodex blepharitis—and how to discuss it with your patients.
Smite the Mite: Current and Emerging Treatments for Demodex Blepharitis
Learn how optometrists can weigh available treatment options for Demodex blepharitis to select the optimal therapy for long-term management of the condition.
Demodex Blepharitis and MGD: New Data on Lotilaner Ophthalmic Solution
Join Preeya K. Gupta, MD, and Damon Dierker, OD, FAAO, to review data on XDEMVY for concurrent Demodex blepharitis and meibomian gland dysfunction.
The Ultimate Guide to Demodex Blepharitis
By properly identifying and diagnosing Demodex blepharitis, you will be able to treat the underlying cause of several ocular surface disorders triggered by mite infestation. Learn everything you need to know about this complex condition.
Overcoming Mite Fright: How to Talk to Patients about Demodex Blepharitis
Review pearls for discussing Demodex blepharitis (DB) with patients and the newly available medical therapy that is changing the treatment paradigm.